LY52 is used in anticancer research; it inhibits MMP-2 and MMP-9, suppresses gelatinase proteolytic activity, reduces MMP-2 and MMP-9 expression in SKOV3 cells, thereby inhibiting cell invasion, and suppresses pulmonary metastasis of Lewis lung carcinoma cells in mice.